New DrugVoice app identifies which clinical messages drive actual prescriptions.
Talking Medicines launches a tool connecting message resonance with real-time prescribing signals.
Talking Medicines has launched a new application within its DrugVoice platform to track prescribing intent. This tool connects message resonance scores with real-time signals from clinical environments.
Pharmaceutical firms spend billions to influence healthcare professionals’ decisions through various forms of communication. However, basic metrics like clicks often fail to reveal actual clinician alignment.
DrugVoice addresses this blind spot by combining data science with pharmacy workflow signals. It identifies which messages resonate with specific clinicians. It also highlights the reasons behind this.
Consequently, these insights help firms identify the practitioners most likely to prescribe certain treatments. CEO Jo Halliday stated that engagement data alone does not show clinician alignment.
Furthermore, she noted the platform determines if a message motivates action. Additionally, the application benchmarks messaging and validates personas across health professional audiences.
It also monitors changes during product launches or medical campaigns. The firm now offers the application through tailored intelligence programmes for industry partners.
(Source: Businesswire)
Read more on Technological News by heading to the 🔗 link.
